BioMarin Pharmaceutical Inc. has made headlines with its announcement of a significant €60 million investment geared towards the expansion of its state-of-the-art facility located in Shanbally, Co. Cork. This ambitious expansion plan encompasses the construction of a new four-story laboratory b
Recent research from Weill Cornell Medicine has unveiled a promising preclinical discovery that could significantly enhance the effectiveness of cancer immunotherapy for B-cell non-Hodgkin lymphomas (B-NHL). The study focuses on the use of EZ## inhibitors, an emerging class of anticancer drugs, in
In recent years, health research has been undergoing two major, yet seemingly opposing, shifts: a deep dive into individual-centric medicine and a broadened focus on population-wide studies. On the individual level, advancements in genomics are driving the shift toward personalized medicine, where
A groundbreaking gene therapy showing promise in preventing premature births and treating placental growth insufficiency holds the potential to significantly improve pregnancies worldwide. This revolutionary therapy is being developed by a dedicated team led by Dr. Helen N. Jones from the
The impact of glyphosate exposure on brain health has been a growing concern, and a new study has brought this issue to the forefront. The research highlights the potential link between the widely used herbicide and lasting brain inflammation, which could lead to neurodegenerative diseases such as
In a strategic move to tackle severe blood cancers, Alanis Therapeutics (ATI) has teamed up with KBI Biopharma to enhance the development and manufacturing of ATI's preclinical antibody candidate, ATI-D1. This partnership aims to accelerate the treatment of myelodysplastic syndromes (MDS) and
Imagine undergoing a medical procedure to remove kidney stones only to face discomfort because of a stent placed to prevent complications. Each year, thousands of patients undergo ureteroscopy to remove kidney stones, and while the procedure is effective, the placement of ureteral stents
Recent advancements in synthetic biology have opened new avenues for addressing antimicrobial resistance (AMR), a pressing global health threat. Synthetic biology encompasses the design and engineering of new or modified living systems to combat drug-resistant bacteria effectively. This field
Cancer treatment has long been challenged by the complexity of tumors that are composed of diverse populations of cancer cells, each reacting differently to treatments. This diversity not only complicates the development of effective treatments but also renders identifying the specific cells
The integration of Artificial Intelligence (AI) in healthcare holds immense potential to revolutionize patient care, clinical decision-making, and operational efficiency. However, realizing this potential requires a structured and responsible approach to ensure safety, equity, and effectiveness.
